Flexible carbon nanotube membrane sensory system: a generic platform

Carbon Nanotube-Based Chemical Sensors

The need to sense gases and vapors arises in numerous scenarios in industrial, environmental, security and medical applications. Traditionally, this activity has utilized bulky instruments to obtain both qualitative and quantitative information on the constituents of the gas mixture. It is ideal to use sensors for this purpose since they are smaller in size and less expensive; however, their performance in the field must match that of established analytical instruments in order to gain acceptance. In this regard, nanomaterials as sensing media offer advantages in sensitivity, preparation of chip-based sensors and construction of electronic nose for selective detection of analytes of interest. This article provides a review of the use of carbon nanotubes in gas and vapor sensing.

Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum

We demonstrate a label-free peptide-coated carbon nanotube-based immunosensor for the direct assay of human serum. A rheumatoid arthritis (RA)-specific (cyclic citrulline-containing) peptide, was immobilized to functionalized single-walled carbon nanotubes deposited on a quartz crystal microbalance (QCM) sensing crystal. Serum from RA patients was used to probe these nanotube-based sensors, and antibody binding was detected by QCM sensing. Specific antibody binding was also determined by comparing the assay of two serum control groups (normal and diseased sera), and the native unmodified peptide. The sensitivity of the nanotube-based sensor (detection in the femtomol range) was higher than that of the established ELISA and recently described microarray assay systems, detecting 34.4 and 37.5% more RA patients with anti-citrullinated peptide antibodies than those found by ELISA and microarray, respectively. There was also an 18.4 and 19.6% greater chance of a negative test being a true indicator of a person not having RA than by either ELISA or microarray, respectively. The performance of our label-free biosensor enables its application in the direct assay of sera in research and diagnostics.

The NASA Smart Probe Project for Real-Time Multiple Microsensor Tissue Recognition

BACKGROUND

Remote surgery requires automated sensors, effectors and sensor-effector communication. The NASA Smart Probe Project has focused on the sensor aspect.

METHODS

The NASA Smart Probe uses neural networks and data from multiple microsensors for a unique tissue signature in real time. Animal and human trials use several probe configurations: (1) 8-microsensor probe (2.5 mm in diameter) for rodent studies (normal and subcutaneous mammary tumor tissues), and (2) 21-gauge needle probe with 3 spectroscopic fibers and an impedance microelectrode for breast cancer diagnosis in humans. Multisensor data are collected in real time (update 100 times/s) using PCs.

RESULTS

Human data (collected by NASA licensee BioLuminate) from 15 women undergoing breast biopsy distinguished normal tissue from both benign tumors and breast carcinoma. Tumor margins and necrosis are rapidly detected.

CONCLUSION

Real-time tissue identification is achievable. Potential applications, including probes incorporating nanoelectrode arrays, are presented.